Arcadia Biosciences Ownership | Who Owns Arcadia Biosciences?
Arcadia Biosciences Ownership Summary
Arcadia Biosciences is owned by 15.46% institutional investors, 0.15% insiders, and 84.39% retail investors. Hrt financial lp is the largest institutional shareholder, holding 1.91% of RKDA shares. Fidelity Extended Market Index is the top mutual fund, with 0.51% of its assets in Arcadia Biosciences shares.
RKDA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Arcadia Biosciences | 15.46% | 0.15% | 84.39% |
| Sector | Basic Materials Stocks | 58.91% | 12.71% | 28.39% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Hrt financial lp | 26.09K | 1.91% | $7.00K |
| Jump financial | 24.30K | 1.78% | $6.80K |
| Geode capital management | 16.14K | 1.18% | $4.52K |
| Vanguard group | 14.04K | 1.03% | $27.80K |
| State street | 12.15K | 0.89% | $3.40K |
| Vanguard capital management | 9.64K | 0.70% | $2.70K |
| Sbi securities | 120.00 | 0.01% | $166.00 |
| Ubs group | 44.00 | 0.00% | $13.00 |
| Group one trading | 18.00 | 0.00% | $5.00 |
| Morgan stanley | 2.00 | 0.00% | $1.00 |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Atticus wealth management | - | - | - |
| Drw securities | - | - | - |
| Mariner | - | - | - |
| Tower research capital llc (trc) | - | - | - |
| Susquehanna group, llp | - | - | - |
| Advisor group | - | - | - |
| Assetmark | - | - | - |
| Jane street group | - | - | - |
| Harbour investments | - | - | - |
| Geode capital management | 16.14K | - | $4.52K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jump financial | 24.30K | - | 24.30K |
| Ubs group | 44.00 | - | 9.00 |
| Geode capital management | 16.14K | - | - |
| State street | 12.15K | - | - |
| Group one trading | 18.00 | - | - |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -159.39K |
| Sabby management | - | - | -114.55K |
| Hrt financial lp | 26.09K | - | -62.29K |
| Stonex group | - | - | -13.68K |
| Susquehanna group, llp | - | - | -12.61K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Jump financial | 24.30K | - | 24.30K | $6.80K |
Sold Out
| Holder | Change |
|---|---|
| Citigroup | -1.00 |
| Caitong asset management | -1.00 |
| Harbour investments | -1.00 |
| Larson financial group | -1.00 |
| Assetmark | -5.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 16 | 6.67% | 211,485 | -39.47% | 15 | 2.37% | 8 | -11.11% | 2 | - |
| Mar 31, 2026 | 8 | -38.46% | 14,991 | -61.67% | 1 | 13.39% | 4 | - | - | -100.00% |
| Dec 31, 2025 | 10 | -37.50% | 37,551 | -42.64% | 2 | 11.98% | - | -100.00% | 5 | 25.00% |
| Sep 30, 2025 | 16 | 23.08% | 65,469 | 12.02% | 4 | 26.17% | 6 | 100.00% | 4 | 100.00% |
| Jun 30, 2025 | 13 | -7.14% | 59,154 | -22.67% | 4 | 13.81% | 3 | -40.00% | 2 | 100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Extended Market Index | 12.37K | 0.51% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 9.64K | 0.40% | - |
| Spartan Extended Market Index Pool E | 2.21K | 0.16% | 64.00 |
| Fidelity Series Total Market Index | 1.72K | 0.07% | - |
| Fidelity Total Market Index | 1.63K | 0.07% | - |
| SSgA U.S. Extended Market Index Class I | 908.00 | 0.07% | - |
| State St US Extended Mkt Indx NL Cl C | 908.00 | 0.04% | - |
| Spartan Total Market Index Pool G | 420.00 | 0.03% | - |
| NT Ext Equity Mkt Index Fund - Lending | 419.00 | 0.03% | - |
| SSgA U.S. Total Market Index Strategy | 374.00 | 0.02% | -7.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 03, 2025 | Kawakami Mark | Chief Financial Officer | Buy | $1.74K |
| Feb 03, 2025 | Schaefer Thomas J. | Chief Executive Officer | Buy | $1.74K |
| Aug 01, 2024 | Kawakami Mark | Chief Financial Officer | Buy | $1.44K |
| Aug 01, 2024 | Schaefer Thomas J. | Chief Executive Officer | Buy | $1.44K |
| Feb 01, 2024 | Schaefer Thomas J. | Chief Financial Officer | Buy | $1.44K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | 2 | - |
| 2024 Q3 | 2 | - |
| 2024 Q1 | 1 | - |
| 2023 Q3 | 1 | - |
| 2023 Q2 | 1 | - |
RKDA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools